Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by bluemoons20on Mar 16, 2021 2:56pm
264 Views
Post# 32809278

NEWS

NEWSThough this news release shows something is happening with the company , the market does not take it as seriously as current shareholders might. This is really just another certification such as we have in Canada , US and Europe. Likely what the 'market' is looking for is actual sales of units. I like the story associated with the company and the product, however , even though some folks seem reluctant to want to talk about 'numbers', that is what the market wants to see and hear. Until we have an actual roll out of a significant number of units, this will likely not go up too much further. I guess I will look at other companies to spend day to day time with and leave this on the shelf until something that is real develops. This will be a waiting game. Until some hospital or group actually puts up some real money, this is just a story about what might be. I would like to see numbers like those bandied about a few weeks ago but sadly , do not see it with mer talk about certifications etc. Given the 'story' associated with this, I would have hoped for more concrete activity by now. but lets wait and see. GLTA
<< Previous
Bullboard Posts
Next >>